

Author: Apweiler Rolf Martin Maria Jesus O’Donovan Claire Pruess Manuela
Publisher: Future Medicine
ISSN: 1462-2416
Source: Pharmacogenomics, Vol.4, Iss.3, 2003-05, pp. : 343-350
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content


Technology: methodologies in genomics and proteomics
International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 2, 2001-04 ,pp. :


Genomics and Proteomics of Nucleoside Transporters
Current Pharmacogenomics, Vol. 3, Iss. 4, 2005-01 ,pp. :


Companies Applying Genomics and Proteomics to Cancer
Pharmaceutical & Diagnostic Innovation, Vol. 1, Iss. 1, 2003-01 ,pp. :


Genomics, proteomics: what’s next?
Pharmacogenomics, Vol. 3, Iss. 6, 2002-11 ,pp. :